Hiroshi Yamada

804 total citations
53 papers, 603 citations indexed

About

Hiroshi Yamada is a scholar working on Pharmacology, Social Psychology and Toxicology. According to data from OpenAlex, Hiroshi Yamada has authored 53 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Social Psychology and 7 papers in Toxicology. Recurrent topics in Hiroshi Yamada's work include Pharmacy and Medical Practices (7 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Mental Health Treatment and Access (6 papers). Hiroshi Yamada is often cited by papers focused on Pharmacy and Medical Practices (7 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Mental Health Treatment and Access (6 papers). Hiroshi Yamada collaborates with scholars based in Japan, United States and India. Hiroshi Yamada's co-authors include Yohei Kawasaki, Kazuki Ide, Shinichiro Tomitaka, Keizo Umegaki, Toshi A. Furukawa, Yutaka Ono, Kunio Yui, Tsuyoshi Chiba, Shuji Maruyama and Shinya Uchida and has published in prestigious journals such as PLoS ONE, Journal of neurosurgery and Transplantation.

In The Last Decade

Hiroshi Yamada

49 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Yamada Japan 15 99 86 83 81 65 53 603
Chung‐Hsuen Wu United States 15 62 0.6× 201 2.3× 73 0.9× 122 1.5× 12 0.2× 47 901
Herman van Wietmarschen Netherlands 18 52 0.5× 226 2.6× 40 0.5× 66 0.8× 103 1.6× 51 895
Shailendra Handu India 13 49 0.5× 71 0.8× 25 0.3× 80 1.0× 34 0.5× 41 1.1k
Xing Liao China 14 139 1.4× 287 3.3× 53 0.6× 79 1.0× 23 0.4× 149 934
Nailya Bulatova Jordan 18 71 0.7× 21 0.2× 46 0.6× 68 0.8× 11 0.2× 61 816
Suzanne Grant Australia 16 62 0.6× 384 4.5× 60 0.7× 116 1.4× 19 0.3× 52 859
Bin Sun China 20 46 0.5× 24 0.3× 137 1.7× 34 0.4× 42 0.6× 55 1.1k
Bhupinder Singh Kalra India 14 149 1.5× 44 0.5× 54 0.7× 94 1.2× 52 0.8× 31 854
Azidah Abdul Kadir Malaysia 17 29 0.3× 45 0.5× 40 0.5× 74 0.9× 31 0.5× 93 795
David Woods New Zealand 15 70 0.7× 35 0.4× 151 1.8× 279 3.4× 21 0.3× 82 1.2k

Countries citing papers authored by Hiroshi Yamada

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Yamada more than expected).

Fields of papers citing papers by Hiroshi Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Yamada. The network helps show where Hiroshi Yamada may publish in the future.

Co-authorship network of co-authors of Hiroshi Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Yamada. A scholar is included among the top collaborators of Hiroshi Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Yamada. Hiroshi Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamada, Hiroshi, et al.. (2025). Audio guide system for small-scale historical buildings. 10(1). 41–52.
3.
Umegaki, Keizo, et al.. (2023). Characteristics of Adverse events of Dietary Supplements Provided byMedical Professionals and their Application in Causality Evaluation Algorithm. Food Hygiene and Safety Science (Shokuhin Eiseigaku Zasshi). 64(1). 13–20.
4.
Ohno, Keiko, et al.. (2018). Apolipoprotein E Gene Polymorphisms Affect the Efficacy of Thiazolidinediones for Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Biological and Pharmaceutical Bulletin. 41(7). 1017–1023. 6 indexed citations
5.
Kawasaki, Yohei, et al.. (2017). Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis. Biological and Pharmaceutical Bulletin. 40(11). 1976–1982. 12 indexed citations
6.
Tomitaka, Shinichiro, Yohei Kawasaki, Kazuki Ide, et al.. (2017). Pattern analysis of total item score and item response of the Kessler Screening Scale for Psychological Distress (K6) in a nationally representative sample of US adults. PeerJ. 5. e2987–e2987. 17 indexed citations
7.
Yui, Kunio, et al.. (2017). Decreased total antioxidant capacity has a larger effect size than increased oxidant levels in urine in individuals with autism spectrum disorder. Environmental Science and Pollution Research. 24(10). 9635–9644. 16 indexed citations
8.
Ide, Kazuki, et al.. (2017). The Safety Profile of Telaprevir-Based Triple Therapy in Clinical Practice: A Retrospective Cohort Study. Biological and Pharmaceutical Bulletin. 40(5). 687–692. 2 indexed citations
9.
Tomitaka, Shinichiro, Yohei Kawasaki, Kazuki Ide, et al.. (2016). Boundary curves of individual items in the distribution of total depressive symptom scores approximate an exponential pattern in a general population. PeerJ. 4. e2566–e2566. 8 indexed citations
10.
11.
Tomitaka, Shinichiro, Yohei Kawasaki, Kazuki Ide, et al.. (2016). Age-related changes in the distributions of depressive symptom items in the general population: a cross-sectional study using the exponential distribution model. PeerJ. 4. e1547–e1547. 9 indexed citations
12.
Kawasaki, Yohei, Kazuki Ide, Hiroshi Yamada, & Naohiko Masaki. (2016). Regional differences in hepatitis C treatment with peginterferon and ribavirin in Japan: a retrospective cohort study. Drug Design Development and Therapy. 10. 1217–1217. 2 indexed citations
13.
Sato, Izumi, et al.. (2015). Clinical Data Interchange Standards Consortium Standardization of Biobank Data: A Feasibility Study. Biopreservation and Biobanking. 14(1). 45–50. 4 indexed citations
14.
Ide, Kazuki, et al.. (2015). Submission Rates of Medication Notebooks in Insurance Pharmacies. 16(4). 201–205. 3 indexed citations
15.
Ide, Kazuki, Hiroshi Yamada, Yohei Kawasaki, et al.. (2015). Methods for estimating causal relationships of adverse events with dietary supplements. BMJ Open. 5(11). e009038–e009038. 18 indexed citations
16.
Umegaki, Keizo, Hiroshi Yamada, Tsuyoshi Chiba, et al.. (2013). Information Sources for Causality Assessment of Health Problems Related to Health Foods and Their Usefulness. Food Hygiene and Safety Science (Shokuhin Eiseigaku Zasshi). 54(4). 282–289. 13 indexed citations
17.
Yamada, Hiroshi, et al.. (2009). . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 40(4). 163–168. 4 indexed citations
18.
Watanabe, Takayuki, et al.. (2009). Study on the Changes in Usage of Generic Drugs in Community Pharmacies Following the 2008 Medical Treatment Fee Revisions. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 40(6). 295–302. 2 indexed citations
19.
Uchida, Shinya, Hiroshi Yamada, Xiao Dong Li, et al.. (2006). Effects of Ginkgo Biloba Extract on Pharmacokinetics and Pharmacodynamics of Tolbutamide and Midazolam in Healthy Volunteers. The Journal of Clinical Pharmacology. 46(11). 1290–1298. 90 indexed citations
20.
Yamada, Hiroshi, Nobuhiko Takai, Yoko Saito, et al.. (2005). Informed Consent Training with Simulated Patients for Clinical Research Coordinator Trainees. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 36(4). 209–213. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026